Mangoceuticals Ownership 2024 | Who Owns Mangoceuticals Now?


OverviewRevenueFinancialsChart

Institutional Ownership

0.06%

Insider Ownership

31.26%

Retail Ownership

68.68%

Institutional Holders

1.00

Mangoceuticals Institutional Shareholders


Institutional Shareholders by % of Total Shares

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
UBS GROUP AG0.06%-4,6654,665100.00%5,318,000Mar 31, 2023

Mangoceuticals's largest institutional shareholder is UBS GROUP AG, holding 0.06% of the company's total share outstanding, currently valued at $5.32M. The top 10 institutional shareholders own together 0.06% of the company.

Institutional Shareholders by % of Total Assets

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
UBS GROUP AG0.06%-4,6654,665100.00%5,318,000Mar 31, 2023

The largest Mangoceuticals shareholder by % of total assets is UBS GROUP AG. The company owns 4.67K shares of Mangoceuticals (MGRX), representing 0.00% of its total assets.

Institutional Buyers

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
UBS GROUP AG0.06%-4,6654,665100.00%5,318,000Mar 31, 2023

As of Mar 31 2023, Mangoceuticals's largest institutional buyer is UBS GROUP AG. The company purchased 4.67K stocks of MGRX, valued at $5.32M.

Institutional Sellers

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
UBS GROUP AG0.06%-4,6654,665100.00%5,318,000Mar 31, 2023

As of Mar 31 2023, Mangoceuticals's biggest institutional seller is UBS GROUP AG. The company sold 4.67K shares of MGRX, valued at $5.32M.

Institutional New positions

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
UBS GROUP AG0.06%-4,6654,665100.00%5,318,000Mar 31, 2023

Mangoceuticals's largest new institutional shareholder by number of shares is UBS GROUP AG, purchased 4.67K shares, valued at $5.32M, as of undefined.

Institutional Sold Out

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate

Mangoceuticals Mutual Fund Holders


Name% Total AssetsTotal SharesChange AmountChange %Date
FIDELITY CONCORD STREET TRUST0.00%6,771--Feb 29, 2024

Mangoceuticals's largest mutual fund holder by % of total assets is "FIDELITY CONCORD STREET TRUST", owning 6.77K shares, compromising 0.00% of its total assets.

Mangoceuticals Institutional Ownership Trends


Institutional Holdings Trend

DateHoldingsChange %
31 Mar, 231-

As of 31 Mar 23, 1 institutions are holding Mangoceuticals's shares, representing an increase of 0.00% compared to the previous quarter.

Shares Outstanding Trend

DateShares OutstandingChange %
31 Mar, 234,665-

Mangoceuticals (MGRX) has 4.67K shares outstanding as of 31 Mar 23, up 0.00% compared to the previous quarter.

Institutional Ownership Trend

DateOwnership %Change %
31 Mar, 230.06%-

Institutional Increased Positions Trend

DateIncreased PositionsChange %
31 Mar, 23--

Institutional Reduced Positions Trend

DateReduced PositionsChange %
31 Mar, 23--

All Institutional Ownership Trend Data

DateHoldingsChange %Shares OutstandingChange %Ownership %Change %Increased PositionsChange %Reduced PositionsChange %
31 Mar, 231-4,665-0.06%-----

Mangoceuticals Insider Shareholders Trades


Open Market Insider Trades

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
Jun 27, 2024Hamilton Alex P.director-S-SaleSell16,574$0.31$5.14K158,426
Jun 27, 2024Hamilton Alex P.director-S-SaleSell108,426$0.32$34.70K50,000
May 02, 2023Cohen Jacob D.director, 10 percent owner, officer Chief Executive OfficerP-PurchaseBuy275,000$1.00$275.00K8,275,000

Open Market Insider Buys

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
May 02, 2023Cohen Jacob D.director, 10 percent owner, officer Chief Executive OfficerP-PurchaseBuy275,000$1.00$275.00K8,275,000

Insider Sells

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
Jun 27, 2024Hamilton Alex P.director-S-SaleSell16,574$0.31$5.14K158,426
Jun 27, 2024Hamilton Alex P.director-S-SaleSell108,426$0.32$34.70K50,000
May 02, 2023Cohen Jacob D.director, 10 percent owner, officer Chief Executive OfficerG-GiftSell8,000,000---
Mar 20, 2023Cohen Jacob D.director, 10 percent owner, officer CEOSell750,000$1.10$825.00K-

All Insider Owners Trades

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
Jun 27, 2024Hamilton Alex P.director-S-SaleSell16,574$0.31$5.14K158,426
Jun 27, 2024Hamilton Alex P.director-S-SaleSell108,426$0.32$34.70K50,000
Jun 05, 2024Hammer Amanda Elizabethofficer Chief Operating OfficerA-AwardBuy100,000--175,000
Jun 05, 2024Hamilton Alex P.director-A-AwardBuy100,000--175,000
Jun 05, 2024MYERS KENNYdirector-A-AwardBuy100,000--175,000
Jun 05, 2024Cohen Jacob D.director, 10 percent owner, officer Chief Executive OfficerA-AwardBuy800,000--800,000
Jun 05, 2024D'Alessio Lorraine Pameladirector-A-AwardBuy100,000--175,000
Dec 29, 2023Cohen Jacob D.director, 10 percent owner, officer Chief Executive OfficerA-AwardBuy125,000$0.32$40.00K1,250,000
Oct 04, 2023JOHNSTON EUGENE Mofficer Chief Financial OfficerA-AwardBuy50,000--200,000
May 02, 2023Cohen Jacob D.director, 10 percent owner, officer Chief Executive OfficerP-PurchaseBuy275,000$1.00$275.00K8,275,000
May 02, 2023Cohen Jacob D.director, 10 percent owner, officer Chief Executive OfficerG-GiftBuy8,000,000--8,000,000
May 02, 2023Cohen Jacob D.director, 10 percent owner, officer Chief Executive OfficerG-GiftSell8,000,000---
Mar 20, 2023Cohen Jacob D.director, 10 percent owner, officer CEOBuy---8,000,000
Mar 20, 2023Cohen Jacob D.director, 10 percent owner, officer CEOSell750,000$1.10$825.00K-

The last insider sell of Mangoceuticals's stock was made by Hamilton Alex P. on Jun 27 2024, selling 16,574 shares at $0.31 per share (valued at $5.14K). The last insider buy of MGRX was made by Cohen Jacob D. on May 02 2023, buying 275,000 shares at $1.00 per share (worth $275.00K).

Mangoceuticals Insider Ownership Trends


All Insider Trades Trend

DateBuySellBuy/Sell Ratio
Q2 202452250.00%
Q4 20232--
Q2 202321200.00%
Q1 2023-1-

5 total buy trades, and 2 total sell trades (buy/sell ratio of 2.50%) were made by Mangoceuticals's insiders, as of Q2 2024.

Open Market Insider Trades Trend

DateBuySellBuy/Sell Ratio
Q2 2024-2-
Q4 2023---
Q2 20231--
Q1 2023---

As of Q2 2024, Insider owners conducted 0 open market buy trades and 2 open market sell trades of Mangoceuticals's stocks.

Mangoceuticals Peer Ownership


TickerCompany
SNCEScience 37 Holdings, Inc.
ETAOETAO International Co., Ltd.
BFRGBullfrog AI Holdings, Inc. Common Stock
HCTIHealthcare Triangle, Inc.
AKLIAkili, Inc.
UTRSMinerva Surgical, Inc.
AUGXAugmedix, Inc.
EUDAEUDA Health Holdings Limited

MGRX Ownership FAQ


Mangoceuticals is owned by institutional shareholders (0.06%), insiders (31.26%), and public (68.68%). The largest institutional shareholder of Mangoceuticals is UBS GROUP AG (0.06% of total shares) and the top mutual fund owner is FIDELITY CONCORD STREET TRUST (0.00% of total shares).

Mangoceuticals's major institutional shareholders are UBS GROUP AG. The top five shareholders own together 0.06% of the company's share outstanding.

As of Mar 2023, there are 1 institutional shareholders of Mangoceuticals.

UBS GROUP AG owns 4.66K shares of Mangoceuticals, representing 0.06% of the company's total shares outstanding, valued at $5.32M (as of Mar 2023).